Elisabeth Bjork serves as Executive at ROCKET PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Elisabeth Bjork has executed 2 insider transactions totaling $34.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 27, 2025 involved purchasing 10,000 shares valued at $34.1K.
Elisabeth Bjork currently holds 40,000 shares of ROCKET PHARMACEUTICALS, INC. (RCKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elisabeth Bjork has been a net buyer of RCKT stock. They have purchased $34.1K and sold $0 worth of shares.
Elisabeth Bjork's most recent insider trade was on Aug 27, 2025, when they purchased 10,000 shares at $3.41 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |